IL152587A0 - Phosphate transport inhibitors - Google Patents

Phosphate transport inhibitors

Info

Publication number
IL152587A0
IL152587A0 IL15258701A IL15258701A IL152587A0 IL 152587 A0 IL152587 A0 IL 152587A0 IL 15258701 A IL15258701 A IL 15258701A IL 15258701 A IL15258701 A IL 15258701A IL 152587 A0 IL152587 A0 IL 152587A0
Authority
IL
Israel
Prior art keywords
transport inhibitors
phosphate transport
phosphate
inhibitors
transport
Prior art date
Application number
IL15258701A
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL152587A0 publication Critical patent/IL152587A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IL15258701A 2000-05-12 2001-05-11 Phosphate transport inhibitors IL152587A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20399500P 2000-05-12 2000-05-12
PCT/US2001/015324 WO2001087294A1 (en) 2000-05-12 2001-05-11 Phosphate transport inhibitors

Publications (1)

Publication Number Publication Date
IL152587A0 true IL152587A0 (en) 2003-05-29

Family

ID=22756167

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15258701A IL152587A0 (en) 2000-05-12 2001-05-11 Phosphate transport inhibitors

Country Status (14)

Country Link
JP (1) JP2003533477A (en)
KR (1) KR20020093983A (en)
CN (1) CN1429108A (en)
AU (1) AU2001261471A1 (en)
BR (1) BR0110034A (en)
CA (1) CA2408667A1 (en)
CZ (1) CZ20023701A3 (en)
HU (1) HUP0302234A2 (en)
IL (1) IL152587A0 (en)
MX (1) MXPA02011160A (en)
NO (1) NO20025399D0 (en)
PL (1) PL359931A1 (en)
WO (1) WO2001087294A1 (en)
ZA (1) ZA200209106B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2378179A (en) * 2001-08-03 2003-02-05 Pantherix Ltd Aromatic sulfonamides and their use in treating bacterial diseases
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
MX345283B (en) 2008-12-31 2017-01-24 Ardelyx Inc Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders.
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
CA2880338A1 (en) 2012-08-21 2014-02-27 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
CN103183623A (en) * 2013-03-12 2013-07-03 中国医学科学院医药生物技术研究所 A group of benzene sulfonamido benzamide derivatives, and preparation and application thereof
KR20230132619A (en) 2013-04-12 2023-09-15 알데릭스, 인코포레이티드 Nhe3-binding compounds and methods for inhibiting phosphate transport
US9765050B2 (en) 2014-12-30 2017-09-19 Novira Therapeutics, Inc. Pyridyl reverse sulfonamides for HBV treatment
CN105395532B (en) * 2015-11-25 2017-11-14 中国医学科学院医药生物技术研究所 Application of the 2 benzene sulfonamido benzamide compounds in liver injury protection and liver fibrosis preventing and treating
WO2018043400A1 (en) * 2016-08-30 2018-03-08 日本曹達株式会社 Sulfonylamino benzamide compound and pest control agent
JP7292207B2 (en) 2017-01-09 2023-06-16 アルデリックス, インコーポレイテッド Compounds Useful for Treating Gastrointestinal Disorders
CA3049679A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Inhibitors of nhe-mediated antiport
US11390599B2 (en) 2018-06-01 2022-07-19 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003502347A (en) * 1999-06-24 2003-01-21 スミスクライン・ビーチャム・コーポレイション Macrophage scavenger receptor antagonist
AR030911A1 (en) * 1999-07-20 2003-09-03 Smithkline Beecham Corp USE OF N-ARIL-2-SULFONAMIDOBENZAMIDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CHRONIC RENAL FAILURE AND PHARMACEUTICAL COMPOSITIONS

Also Published As

Publication number Publication date
CZ20023701A3 (en) 2003-11-12
KR20020093983A (en) 2002-12-16
JP2003533477A (en) 2003-11-11
AU2001261471A1 (en) 2001-11-26
NO20025399L (en) 2002-11-11
MXPA02011160A (en) 2003-03-10
BR0110034A (en) 2003-05-27
HUP0302234A2 (en) 2003-11-28
NO20025399D0 (en) 2002-11-11
CN1429108A (en) 2003-07-09
WO2001087294A1 (en) 2001-11-22
CA2408667A1 (en) 2001-11-22
PL359931A1 (en) 2004-09-06
ZA200209106B (en) 2003-10-23

Similar Documents

Publication Publication Date Title
AU2002213048A1 (en) Phosphate transport inhibitors
GB9900416D0 (en) Inhibitors
IL146518A0 (en) Metalloprotease inhibitors
IL147697A0 (en) Phosphate transport inhibitors
PL343435A1 (en) Glycine transport inhibitors
IL138227A0 (en) Glycine transport inhibitors
AU3408801A (en) Tnf-alpha inhibitors
EP1324759A4 (en) Nf-g(k)b inhibitors
AU2001259354A1 (en) Phosphate transport inhibitors
IL145085A0 (en) Dihetero-substituted metalloprotease inhibitors
IL152587A0 (en) Phosphate transport inhibitors
AU1876002A (en) Transport system
MXPA03000642A (en) Novel compounds and their use as glycine transport inhibitors.
HK1042695A1 (en) Prothease inhibitors
GB0030284D0 (en) Enzyme inhibitors
GB0004299D0 (en) Corrosion inhibitors
GB2369100B (en) Transport skid
GB0015996D0 (en) Inhibitors
GB0021193D0 (en) Inhibitors
GB0029730D0 (en) Inhibitors
GB0029733D0 (en) Inhibitors
SI1301502T1 (en) Compounds and their use as glycine transport inhibitors
GB0006009D0 (en) Transport
GB9900413D0 (en) Inhibitors
GB9917294D0 (en) Inhibitors